Transcription syndromes and the role of RNA polymerase II general transcription factors in human disease.
Aso
T
T
Program in Molecular and Cell Biology, Oklahoma Medical Research Foundation, Oklahoma City, 73104, USA.
Shilatifard
A
A
Conaway
J W
JW
Conaway
R C
RC
D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D000075065:Elongin; D015870:Gene Expression; D016147:Genes, Tumor Suppressor; D030342:Genetic Diseases, Inborn / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000378:metabolism; D009363:Neoplasm Proteins; D010445:Peptide Elongation Factors; D011401:Promoter Regions, Genetic; D012319:RNA Polymerase II / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic; D035602:Transcriptional Elongation Factors; D006623:von Hippel-Lindau Disease / Q000235:genetics / Q000378:metabolism
D004268:DNA-Binding Proteins; C090862:ELL protein, human; D000075065:Elongin; D009363:Neoplasm Proteins; D010445:Peptide Elongation Factors; D012333:RNA, Messenger; D014157:Transcription Factors; D035602:Transcriptional Elongation Factors; D012319:RNA Polymerase II